These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 23293895)

  • 41. Patient satisfaction after the treatment of glabellar lines with Botulinum toxin type A (Speywood Unit): a multi-centre European observational study.
    Molina B; Grangier Y; Mole B; Ribe N; Martín Diaz L; Prager W; Paliargues F; Kerrouche N
    J Eur Acad Dermatol Venereol; 2015 Jul; 29(7):1382-8. PubMed ID: 25495499
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The wrinkles soothing effect on the middle and lower face by intradermal injection of botulinum toxin type A.
    Chang SP; Tsai HH; Chen WY; Lee WR; Chen PL; Tsai TH
    Int J Dermatol; 2008 Dec; 47(12):1287-94. PubMed ID: 19126019
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A two-phase, retrospective analysis evaluating efficacy of and patient satisfaction with abobotulinumtoxina used to treat dynamic facial rhytides.
    Kiripolsky MG; Peterson JD; Guiha I; Goldman MP
    Dermatol Surg; 2011 Oct; 37(10):1443-7. PubMed ID: 21649790
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Treatment of axillary hyperhidrosis with botulinum toxin type A reconstituted in lidocaine or in normal saline: a randomized, side-by-side, double-blind study.
    Vadoud-Seyedi J; Simonart T
    Br J Dermatol; 2007 May; 156(5):986-9. PubMed ID: 17286630
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Botulinum toxin type A for the treatment of trigeminal neuralgia: results from a randomized, double-blind, placebo-controlled trial.
    Wu CJ; Lian YJ; Zheng YK; Zhang HF; Chen Y; Xie NC; Wang LJ
    Cephalalgia; 2012 Apr; 32(6):443-50. PubMed ID: 22492424
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Midface lifting with botulinum toxin: intradermal technique.
    Petchngaovilai C
    J Cosmet Dermatol; 2009 Dec; 8(4):312-6. PubMed ID: 19958437
    [TBL] [Abstract][Full Text] [Related]  

  • 47. On the effects of a plant extract of Orthosiphon stamineus on sebum-related skin imperfections.
    Vogelgesang B; Abdul-Malak N; Reymermier C; Altobelli C; Saget J
    Int J Cosmet Sci; 2011 Feb; 33(1):44-52. PubMed ID: 20807263
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Treatment effects of intradermal botulinum toxin type A injection on alopecia areata.
    Cho HR; Lew BL; Lew H; Sim WY
    Dermatol Surg; 2010 Dec; 36 Suppl 4():2175-81. PubMed ID: 21134049
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A Comparative
    Cao Y; Yang JP; Zhu XG; Zhu J; Chang HQ; Guo SH; Luo D; Zhou BR
    Biomed Res Int; 2018; 2018():6235742. PubMed ID: 30057908
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The comparison between intradermal injection of abobotulinumtoxinA and normal saline for face-lifting: a split-face randomized controlled trial.
    Wanitphakdeedecha R; Ungaksornpairote C; Kaewkes A; Rojanavanich V; Phothong W; Manuskiatti W
    J Cosmet Dermatol; 2016 Dec; 15(4):452-457. PubMed ID: 27647769
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Long-term treatment of glabellar rhytides using onabotulinumtoxina.
    Dailey RA; Philip A; Tardie G
    Dermatol Surg; 2011 Jul; 37(7):918-28. PubMed ID: 21575099
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Evaluation and selecting indications for the treatment of improving facial morphology by masseteric injection of botulinum toxin type A.
    Gaofeng L; Jun T; Bo P; Bosheng Z; Qian Z; Dongping L
    J Plast Reconstr Aesthet Surg; 2010 Dec; 63(12):2026-31. PubMed ID: 20116356
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Botulinum toxin for Frey's syndrome: a closer look at different treatment responses.
    Steffen A; Rotter N; König IR; Wollenberg B
    J Laryngol Otol; 2012 Feb; 126(2):185-9. PubMed ID: 22018335
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Botulinum Neurotoxin Type A in the Treatment of Facial Seborrhea and Acne: Evidence and a Proposed Mechanism.
    Rho NK; Gil YC
    Toxins (Basel); 2021 Nov; 13(11):. PubMed ID: 34822601
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Treatment of Frey's syndrome with botulinum toxin.
    Pomprasit M; Chintrakarn C
    J Med Assoc Thai; 2007 Nov; 90(11):2397-402. PubMed ID: 18181326
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Therapeutic effectiveness of botulinum toxin type A based on severity of palmar hyperhidrosis.
    Ito K; Yanagishita T; Ohshima Y; Tamada Y; Watanabe D
    J Dermatol; 2011 Sep; 38(9):859-63. PubMed ID: 21545498
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Correlation between Dermatology Life Quality Index and Minor test and differences in their levels over time in patients with axillary hyperhidrosis treated with botulinum toxin type A.
    Skroza N; Bernardini N; La Torre G; La Viola G; Potenza C
    Acta Dermatovenerol Croat; 2011; 19(1):16-20. PubMed ID: 21489361
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Diffusion of two botulinum toxins type A on the forehead: double-blinded, randomized, controlled study.
    Jiang HY; Chen S; Zhou J; Leung KK; Yu P
    Dermatol Surg; 2014 Feb; 40(2):184-92. PubMed ID: 24438121
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Notalgia paresthetica: treatment using intradermal botulinum toxin A.
    Pérez-Pérez L; García-Gavín J; Allegue F; Caeiro JL; Fabeiro JM; Zulaica A
    Actas Dermosifiliogr; 2014; 105(1):74-7. PubMed ID: 24378421
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Is botulinum toxin type a intraprostatic injections really effective in patients with urinary retention?
    Jasiński M; Drewa T; Tyloch J; Wolski Z
    Acta Pol Pharm; 2011; 68(5):765-8. PubMed ID: 21928723
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.